Nature Communications (Apr 2022)

Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing

  • Nina Frey,
  • Luigi Tortola,
  • David Egli,
  • Sharan Janjuha,
  • Tanja Rothgangl,
  • Kim Fabiano Marquart,
  • Franziska Ampenberger,
  • Manfred Kopf,
  • Gerald Schwank

DOI
https://doi.org/10.1038/s41467-022-29412-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Pancreatic cancer is characterized by an immunosuppressive microenvironment, leading to immune evasion. Here, based on in vitro and in vivo CRISPR screens, the authors identify Rnf31 and Vps4b as drivers of immune escape, showing that loss of their function leads to an increase in T cell-mediated killing and reduced tumor growth in preclinical pancreatic cancer models.